Description of Collaborative Activity: |
The Consortium seeks to establish a robust biorepository of well-documented clinical specimens to support the discovery and qualification of biomarkers of Tuberculosis (TB) drug effect, especially surrogate markers for stable cure vs. relapse, and to facilitate development of rapid, reliable TB diagnostics, including tests for drug-susceptibility that would be practical for use in resource poor settings.
. |
